SCHEMBL30845396

SCHEMBL30845396

CC(C)NC(=O)CN1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.57
CHRM3 P20309 2/20 0.53
CHRM5 P08912 1/20 0.53
CHRM2 P08172 1/20 0.48
CHRM4 P08173 1/20 0.48
CHRM1 P11229 1/20 0.48
SIGMAR1 Q99720 2/20 0.47
NPC1 O15118 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
RAB9A P51151 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
KDM4E B2RXH2 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
USP2 O75604 1/20 0.44
EPHX1 P07099 1/20 0.43
HPGD P15428 1/20 0.41
EPHX2 P34913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19928689 0.86 ALDH1A1 (0.43) ALDH1A1CHRM3CHRM2CHRM4CHRM1
SCHEMBL17271431 0.83 CHRM2 (0.51) ALDH1A1CHRM3CHRM2CHRM4CHRM1
SCHEMBL26129355 0.82 ALDH1A1 (0.60) ALDH1A1CHRM3CHRM2CHRM4CHRM1
SCHEMBL15629359 0.82 CHRM2 (0.50) ALDH1A1CHRM3CHRM2CHRM4CHRM1
SCHEMBL31479199 0.81 CHRM2 (0.52) ALDH1A1CHRM3CHRM2CHRM4CHRM1
SCHEMBL23464917 0.80 CHRM5 (0.75) ALDH1A1CHRM3CHRM5SIGMAR1NPC1
SCHEMBL14204029 0.80 CYP1A2 (0.55) ALDH1A1NPC1MAPTMAPK1HTT
SCHEMBL30845441 0.79 ALDH1A1 (0.39) ALDH1A1CHRM3CHRM5SIGMAR1NPC1
SCHEMBL18502954 0.79 ALDH1A1 (0.39) ALDH1A1CHRM3CHRM5NPC1MAPT
SCHEMBL4360565 0.78 CHRM2 (0.52) ALDH1A1CHRM3CHRM2CHRM4CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113423711-B Thieno [3,2-B ] pyridine derivatives as UDP glycosyltransferase inhibitors and methods of use thereof 建新公司 2024-03-15 CN disclosed